These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Angiotensin(1-7) attenuates left ventricular dysfunction and myocardial apoptosis on rat model of adriamycin-induced dilated cardiomyopathy]. Liu HZ; Gao CY; Wang XQ; Fu HX; Yang HH; Wang XP; Liu YH; Li MW; Niu ZM; Dai GY; Qi DT; Zhang Y Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Mar; 40(3):219-24. PubMed ID: 22801267 [TBL] [Abstract][Full Text] [Related]
5. A canine model of dilated cardiomyopathy induced by repetitive intracoronary doxorubicin administration. Toyoda Y; Okada M; Kashem MA J Thorac Cardiovasc Surg; 1998 Jun; 115(6):1367-73. PubMed ID: 9628680 [TBL] [Abstract][Full Text] [Related]
6. Comparative effects of perindopril with enalapril in rats with dilated cardiomyopathy. Watanabe K; Saito Y; Ma M; Wahed M; Abe Y; Hirabayashi K; Narasimman G; Wen J; Suresh P; Ali F; Shirai K; Soga M; Nagai Y; Nakazawa M; Hasegawa G; Naito M; Tachikawa H; Kodama M; Aizawa Y; Yamaguchi K; Takahashi T J Cardiovasc Pharmacol; 2003 Dec; 42 Suppl 1():S105-9. PubMed ID: 14871039 [TBL] [Abstract][Full Text] [Related]
7. Impact of repeated intravenous bone marrow mesenchymal stem cells infusion on myocardial collagen network remodeling in a rat model of doxorubicin-induced dilated cardiomyopathy. Yu Q; Li Q; Na R; Li X; Liu B; Meng L; Liutong H; Fang W; Zhu N; Zheng X Mol Cell Biochem; 2014 Feb; 387(1-2):279-85. PubMed ID: 24257807 [TBL] [Abstract][Full Text] [Related]
8. Bone marrow mononuclear cell transplantation had beneficial effects on doxorubicin-induced cardiomyopathy. Ishida M; Tomita S; Nakatani T; Fukuhara S; Hamamoto M; Nagaya N; Ohtsu Y; Suga M; Yutani C; Yagihara T; Yamada K; Kitamura S J Heart Lung Transplant; 2004 Apr; 23(4):436-45. PubMed ID: 15063403 [TBL] [Abstract][Full Text] [Related]
9. Effect of the addition of a beta-blocker on left ventricular remodeling and prognosis in patients with dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitor. Hamada M; Hara Y; Ohtsuka T; Suzuki J; Saeki H; Ogimoto A; Shigematsu Y J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S5-10. PubMed ID: 12688389 [TBL] [Abstract][Full Text] [Related]
11. Early myocardial changes induced by doxorubicin in the nonfailing dilated ventricle. Rodrigues PG; Miranda-Silva D; Costa SM; Barros C; Hamdani N; Moura C; Mendes MJ; Sousa-Mendes C; Trindade F; Fontoura D; Vitorino R; Linke WA; Leite-Moreira AF; Falcão-Pires I Am J Physiol Heart Circ Physiol; 2019 Mar; 316(3):H459-H475. PubMed ID: 30525890 [TBL] [Abstract][Full Text] [Related]
12. Simultaneous angiotensin converting enzyme inhibition moderates ventricular dysfunction caused by doxorubicin. Vaynblat M; Shah HR; Bhaskaran D; Ramdev G; Davis WJ; Cunningham JN; Chiavarelli M Eur J Heart Fail; 2002 Oct; 4(5):583-6. PubMed ID: 12413500 [TBL] [Abstract][Full Text] [Related]
13. Developing a rat model of dilated cardiomyopathy with improved survival. Shen LJ; Lu S; Zhou YH; Li L; Xing QM; Xu YL J Zhejiang Univ Sci B; 2016 Dec.; 17(12):975-983. PubMed ID: 27921402 [TBL] [Abstract][Full Text] [Related]
14. Short-term and long-term models of doxorubicin-induced cardiomyopathy in rats: A comparison of functional and histopathological changes. O'Connell JL; Romano MM; Campos Pulici EC; Carvalho EE; de Souza FR; Tanaka DM; Maciel BC; Salgado HC; Fazan-Júnior R; Rossi MA; Simões MV Exp Toxicol Pathol; 2017 Apr; 69(4):213-219. PubMed ID: 28153388 [TBL] [Abstract][Full Text] [Related]
15. Comparison of three doses of enalapril in preventing left ventricular remodeling after acute myocardial infarction in the rat. Yang Y; Zhang P; Song L; Ruan Y; Xu X; Li Y; Zhou Y; Tian Y; Xu Y; Chen Z Chin Med J (Engl); 2002 Mar; 115(3):347-51. PubMed ID: 11940361 [TBL] [Abstract][Full Text] [Related]
16. Girdling effect of adynamic cardiomyoplasty in a model of dilated cardiomyopathy. Ootaki Y; Tsukube T; Okita Y Jpn J Thorac Cardiovasc Surg; 2002 Mar; 50(3):104-8. PubMed ID: 11968716 [TBL] [Abstract][Full Text] [Related]
17. Plication of the free wall of the left ventricle in dogs with doxorubicin-induced cardiomyopathy. de Andrade JN; Camacho AA; Santos PS; Fantinatti AP; Nunes N; Stopiglia AJ Am J Vet Res; 2005 Feb; 66(2):238-43. PubMed ID: 15757121 [TBL] [Abstract][Full Text] [Related]
18. A stable model of chronic bilateral ventricular insufficiency (dilated cardiomyopathy) induced by arteriovenous anastomosis and doxorubicin administration in sheep. Chekanov VS J Thorac Cardiovasc Surg; 1999 Jan; 117(1):198-9. PubMed ID: 9869781 [No Abstract] [Full Text] [Related]
19. Left ventricular function in patients with toxic cardiomyopathy and with idiopathic dilated cardiomyopathy treated with Doxorubicin. Katamadze NA; Lartsuliani KP; Kiknadze MP Georgian Med News; 2009 Jan; (166):43-8. PubMed ID: 19202217 [TBL] [Abstract][Full Text] [Related]
20. Activation of matrix metalloproteinases precedes left ventricular remodeling in hypertensive heart failure rats: its inhibition as a primary effect of Angiotensin-converting enzyme inhibitor. Sakata Y; Yamamoto K; Mano T; Nishikawa N; Yoshida J; Hori M; Miwa T; Masuyama T Circulation; 2004 May; 109(17):2143-9. PubMed ID: 15051632 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]